VINCA MINOR pellet

Ülke: ABD

Dil: İngilizce

Kaynak: NLM (National Library of Medicine)

Aktif bileşen:

VINCA MINOR (UNII: WGM46PQF02) (VINCA MINOR - UNII:WGM46PQF02)

Mevcut itibaren:

Rxhomeo Private Limited d.b.a. Rxhomeo, Inc

Uygulama yolu:

ORAL

Reçete türü:

OTC DRUG

Terapötik endikasyonlar:

Scalp Eczema Condition listed above or as directed by the physician

Yetkilendirme durumu:

unapproved homeopathic

Ürün özellikleri

VINCA MINOR- VINCA MINOR PELLET
RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug Administration for_
_safety or efficacy. FDA is not aware of scientific evidence to
support homeopathy as effective._
----------
ACTIVE INGREDIENT
VINCA MINOR HPUS 3X and higher
USES
Scalp Eczema
INDICATIONS
Condition listed above or as directed by the physician
DOSAGE
Adults- Take 4 or 6 Pellets by mouth, three times daily or as
suggested by physician. Children 2 years
and older- take 1/2 the adult dose.
WARNINGS
This product is to be used for self-limiting conditions
If symptoms do not improve in 4 days, or worsen, discontinue use and
seek assistance of health
professional
As with any drug, if you are preganant, or nursing a baby, seek
professional advice before taking this
product
Keep this and all medication out of reach of children
Do not use if capseal is broken or missing.
Close the cap tightly after use.
INACTIVE INGREDIENTS
Sucrose
STORAGE
Store in a cool dark place
QUESTIONS OR COMMENTS
www.Rxhomeo.com | 1.888.2796642 | [e-mail]
Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758
VINCA MINOR
vinca minor pellet
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:156 31-0 46 0
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
VINCA MINO R (UNII: WGM46 PQF0 2) (VINCA MINOR - UNII:WGM46 PQF0 2)
VINCA MINOR
3 [hp_X]
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SUCRO SE (UNII: C151H8 M554)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:156 31-0 46 0 -
0
10 0 in 1 VIAL, SINGLE-DOSE; Type 0 : No t a Co mbinatio n
Pro duc t
0 1/0 1/20 18
2
NDC:156 31-0 46 0 -
1
20 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct
0 1/0 1/20 18
3
NDC:156 31-0 46 0 -
2
40 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct
0 1/0 1/20 18
4
NDC:156 31-0 46 0 -
3
750 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct
0 1/0 1/20 18
5